[1]
O. Karcioglu, G. Afacan, B. Ilkuplu, and S. Yeniocak, “Update in Glycoprotein IIb/IIIa Receptor Antagonist Clopidogrel: Use in Cerebrovascular Accidents”, J. Neurol. Epidemiol., vol. 6, pp. 1–6, Mar. 2019.